Vita Coco Company, Inc.
For the period ended Jun 30, 2025. Filed Jul 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Jul 30, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
On May 8, 2025, Verlinvest Beverages SA, a significant stockholder of the Company, completed a block sale of 3,766,762 shares of the Company’s common stock at a price of $34.25 per share in a private transaction facilitated by Bank of America Securities, Inc. The transaction was executed pursuant to Rule 144 under the Securities Act of 1933, as amended.
Following the transaction, Verlinvest Beverages SA beneficially owns approximately 12.5% of the Company’s outstanding common stock, down from 19.1% prior to the transaction.
The transaction does not affect the Company’s capital structure or operations. This sale was undertaken as part of Verlinvest Beverages SA’s ongoing portfolio management strategy and does not reflect any disagreement with the Company’s management or operations.
Rule 10b5-1 Trading Plans
In accordance with the disclosure requirements set forth in Item 408(a) of Regulation S-K, the following table discloses any officer (as defined in Rule 16a-1(f) under the Exchange Act), director, or entity controlled by such officer or director who adopted or terminated a contract, instruction, or written plan for the sale of securities of the Company intended to satisfy the affirmative defense of Rule 10b5-1(c) during the quarterly period ended June 30, 2025:
| Name | Title | Action Taken | Date of Action | Duration of Trading Arrangement | Aggregate Number of Securities to be Sold |
|---|---|---|---|---|---|
| Corey Baker | Chief Financial Officer | Adoption | May 12, 2025 | August 11, 2025 to March 31, 2026 | Up to 10,000 shares of Common Stock, subject to a daily maximum of 1,000 shares |
| The Michael Kirban 2012 Trust | A trust controlled by Michael Kirban (Co-Founder, Executive Chairman and Chairman of the Board) | Adoption | June 5, 2025 | September 4, 2025 to September 30, 2026 | Up to 150,000 shares of Common Stock, subject to a daily maximum of 30,000 shares |
| Ira Liran | Director | Adoption | May 7, 2025 | August 8, 2025 to August 10, 2026 | Up to 180,000 shares of Common Stock |
| The Ira Liran 2012 Family Trust | A trust controlled by Ira Liran | Adoption | May 7, 2025 | August 8, 2025 to August 10, 2026 | Up to 270,000 shares of Common Stock |
| Charles Van Es | Chief Sales Officer | Adoption | June 13, 2025 | September 12, 2025 to March 15, 2026 | Up to 60,000 shares of Common Stock |
Other than as disclosed above, no other officer, director or entity controlled by such officer or director adopted, modified orterminated a contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense of Rule 10b5-1(c) or a non-Rule 10b5-1 trading arrangement.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.